Applied Therapeutics, Inc. (APLT)

Applied Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	30.42	79.4	49.9	16.66	53.89	57.47
Short-Term Investments	-	-	-	13.92	26.94	39.36
Cash & Short-Term Investments	30.42	79.4	49.9	30.58	80.82	96.83
Cash Growth	-75.11%	59.12%	63.17%	-62.16%	-16.53%	149.21%
Other Receivables	-	-	-	0.28	0.53	0.51
Receivables	-	-	-	0.28	0.53	0.51
Prepaid Expenses	4.09	1.74	1.35	2.12	2.56	2.91
Other Current Assets	-	2.51	3.13	4.33	4.48	2.35
Total Current Assets	34.51	83.65	54.39	37.31	88.39	102.59
Property, Plant & Equipment	2.58	2.79	0.45	0.86	1.3	1.71
Other Long-Term Assets	0.25	0.25	-	0.2	0.2	0.2
Total Assets	37.34	86.69	54.83	38.36	89.89	104.51
Accounts Payable	4.86	4.43	1.74	4.53	9.46	0.64
Accrued Expenses	10.67	15.33	13.93	13.65	14.78	18.56
Short-Term Debt	-	-	0.31	0.62	0.79	1.07
Current Portion of Leases	0.45	0.41	0.43	0.48	0.44	0.41
Current Unearned Revenue	-	0.21	0.67	-	-	-
Other Current Liabilities	1.77	6.92	54.1	14.14	0.99	0.55
Total Current Liabilities	17.75	27.3	71.18	33.42	26.46	21.24
Long-Term Leases	2.16	2.39	0.04	0.41	0.89	1.33
Other Long-Term Liabilities	-	-	0.76	0.46	-	-
Total Liabilities	19.9	29.69	71.98	34.3	27.35	22.57
Common Stock	0.04	0.04	0.01	0.01	0	0
Additional Paid-In Capital	634.77	631.18	451.43	352.83	328.96	242.78
Retained Earnings	-617.37	-574.21	-468.59	-348.82	-266.32	-160.73
Comprehensive Income & Other	-	-	-	0.05	-0.11	-0.11
Total Common Equity	17.44	57.01	-17.15	4.06	62.54	81.94
Shareholders' Equity	17.44	57.01	-17.15	4.06	62.54	81.94
Total Liabilities & Equity	37.34	86.69	54.83	38.36	89.89	104.51
Total Debt	2.6	2.8	0.78	1.51	2.12	2.81
Net Cash (Debt)	27.82	76.6	49.12	29.07	78.7	94.02
Net Cash Growth	-77.19%	55.95%	68.99%	-63.07%	-16.29%	155.38%
Net Cash Per Share	0.19	0.55	0.58	0.77	3.07	4.28
Filing Date Shares Outstanding	144.01	141.58	105.89	48.11	26.22	26.01
Total Common Shares Outstanding	141.94	137.23	84.87	48.06	26.22	22.49
Working Capital	16.76	56.35	-16.8	3.88	61.93	81.36
Book Value Per Share	0.12	0.42	-0.20	0.08	2.39	3.64
Tangible Book Value	17.44	57.01	-17.15	4.06	62.54	81.94
Tangible Book Value Per Share	0.12	0.42	-0.20	0.08	2.39	3.64

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q